Debjit Chattopadhyay

Stock Analyst at Guggenheim

(0.81)
# 2351
Out of 5,386 analysts
112
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
37 Stocks
Name Action PT Current % Upside Ratings Updated
RARE Ultragenyx Pharmaceu...
Reiterates: Buy
64 64
36.51 75.29% 3 Jun 20, 2025
DYN Dyne Therapeutics
Reiterates: Buy
50 50
9.59 421.38% 5 Jun 18, 2025
QURE uniQure
Reiterates: Buy
28 28
13.83 102.46% 6 May 12, 2025
NTLA Intellia Therapeutic...
Maintains: Buy
55 45
9.56 370.71% 2 May 12, 2025
SLNO Soleno Therapeutics
Maintains: Strong Buy
81 97
83.24 16.53% 3 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
195 189
138.96 36.01% 4 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
78 55
16.8 227.38% 3 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
112 98
17.1 473.1% 5 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 64
39.83 60.68% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
12.2 55.74% 2 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
13.14 113.09% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
2.42 643.8% 3 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
17 17
11.29 50.58% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
5.94 152.53% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
450 558
441.18 26.48% 6 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
4.3 341.86% 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
2.96 643.24% 1 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
18.58 61.46% 1 Jan 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110
55.12 99.56% 3 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 29
1.18 2357.63% 1 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 11
n/a n/a 2 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 51
n/a n/a 4 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
2.4 1066.67% 1 Dec 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
255
n/a n/a 1 May 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
20
6.66 200.3% 2 Dec 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
11
n/a n/a 5 Dec 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
270 123
27.99 339.44% 8 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
12.45 333.73% 3 Jul 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
420 156
n/a n/a 3 Mar 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
60
1.03 5725.24% 3 Dec 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
75 90
n/a n/a 5 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 4
n/a n/a 2 Mar 4, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2017